118 related articles for article (PubMed ID: 7229115)
1. Lidocaine kinetics: relationships between early lidocaine kinetics and indocyanine green clearance.
Zito RA; Reid PR
J Clin Pharmacol; 1981; 21(2):100-5. PubMed ID: 7229115
[TBL] [Abstract][Full Text] [Related]
2. Lidocaine kinetics predicted by indocyanine green clearance.
Zito RA; Reid PR
N Engl J Med; 1978 May; 298(21):1160-3. PubMed ID: 651945
[TBL] [Abstract][Full Text] [Related]
3. Influence of viral hepatitis on the disposition of two compounds with high hepatic clearance: lidocaine and indocyanine green.
Williams RL; Blaschke TF; Meffin PJ; Melmon KL; Rowland M
Clin Pharmacol Ther; 1976 Sep; 20(3):290-9. PubMed ID: 954351
[TBL] [Abstract][Full Text] [Related]
4. Lignocaine and indocyanine green kinetics in patients following myocardial infarction.
Bax ND; Tucker GT; Woods HF
Br J Clin Pharmacol; 1980 Oct; 10(4):353-61. PubMed ID: 7448106
[TBL] [Abstract][Full Text] [Related]
5. Effect of portacaval shunt on drug disposition in patients with cirrhosis.
Pomier-Layrargues G; Huet PM; Villeneuve JP; Marleau D
Gastroenterology; 1986 Jul; 91(1):163-7. PubMed ID: 3710065
[TBL] [Abstract][Full Text] [Related]
6. Effects of smoking and chronic hepatitis B on lidocaine and indocyanine green kinetics.
Huet PM; Lelorier J
Clin Pharmacol Ther; 1980 Aug; 28(2):208-15. PubMed ID: 7398188
[TBL] [Abstract][Full Text] [Related]
7. Assessment of hepatic function in cystic fibrosis by lidocaine metabolism.
Gremse DA; Sindel LJ; Hoff CJ; Wells DJ; Boerth RC
J Pediatr Gastroenterol Nutr; 2001 Apr; 32(4):434-7. PubMed ID: 11396809
[TBL] [Abstract][Full Text] [Related]
8. Effect of H2-receptor antagonists on steady-state extraction of indocyanine green and lidocaine by the perfused rat liver.
Roberts RK; Heath CA; Johnson RF; Speeg KV; Schenker S
J Lab Clin Med; 1986 Feb; 107(2):112-7. PubMed ID: 2868064
[TBL] [Abstract][Full Text] [Related]
9. Assessment of metabolic liver function and hepatic blood flow during cardiopulmonary bypass.
Autschbach R; Falk V; Lange H; Oellerich M; Walther T; Mohr FW; Dalichau H
Thorac Cardiovasc Surg; 1996 Apr; 44(2):76-80. PubMed ID: 8782332
[TBL] [Abstract][Full Text] [Related]
10. The influence of dye infusion rate and hepatic plasma flow on indocyanine green clearance.
Krarup N; Larsen JA
Scand J Clin Lab Invest; 1976 Mar; 36(2):183-8. PubMed ID: 1273495
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients.
Kawasaki S; Sugiyama Y; Iga T; Hanano M; Sanjo K; Beppu T; Idezuki Y
Am J Gastroenterol; 1985 Oct; 80(10):801-6. PubMed ID: 4036939
[TBL] [Abstract][Full Text] [Related]
12. Determinants of drug disposition in patients with cirrhosis.
Huet PM; Villeneuve JP
Hepatology; 1983; 3(6):913-8. PubMed ID: 6629320
[TBL] [Abstract][Full Text] [Related]
13. The effect of PGE2 on hepatic blood flow and bile indocyanin green in the rat.
Bruck R; Krepel Z; Melzer E; Bar-Meir S
Prostaglandins; 1989 May; 37(5):531-8. PubMed ID: 2740524
[TBL] [Abstract][Full Text] [Related]
14. Lidocaine and indocyanine green kinetics: effect of hypoxemia and/or hypercapnia.
Marleau S; Ong H; Gariépy L; du Souich P
J Pharmacol Exp Ther; 1987 Jul; 242(1):338-43. PubMed ID: 3112366
[TBL] [Abstract][Full Text] [Related]
15. Hepatic function as assessed by lidocaine metabolism in sickle cell disease.
Gremse DA; Fillingim E; Hoff CJ; Wells DJ; Boerth RC
J Pediatr; 1998 Jun; 132(6):989-93. PubMed ID: 9627591
[TBL] [Abstract][Full Text] [Related]
16. Clearance and non-invasive determination of the hepatic extraction of indocyanine green in baboons and man.
Grainger SL; Keeling PW; Brown IM; Marigold JH; Thompson RP
Clin Sci (Lond); 1983 Feb; 64(2):207-12. PubMed ID: 6822056
[TBL] [Abstract][Full Text] [Related]
17. Hepatic blood flow: accuracy of estimation from infusions of indocyanine green in anaesthetized cats.
Burczynski FJ; Greenway CV; Sitar DS
Br J Pharmacol; 1987 Jul; 91(3):651-9. PubMed ID: 3607371
[TBL] [Abstract][Full Text] [Related]
18. The monoethylglycinexylidide test is more useful for evaluating liver function than indocyanine green test: case of a patient with remarkably decreased indocyanine green half-life.
Oda Y; Kariya N; Nakamoto T; Nishi S; Asada A; Fujimori M
Ther Drug Monit; 1995 Apr; 17(2):207-10. PubMed ID: 7624913
[TBL] [Abstract][Full Text] [Related]
19. The kinetics of continuously infused indocyanine green in the pig.
Ott P; Bass L; Keiding S
J Pharmacokinet Biopharm; 1996 Feb; 24(1):19-44. PubMed ID: 8827582
[TBL] [Abstract][Full Text] [Related]
20. Methodological problems in the use of indocyanine green to estimate hepatic blood flow and ICG clearance in man.
Skak C; Keiding S
Liver; 1987 Jun; 7(3):155-62. PubMed ID: 3613884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
